Thompson Siegel & Walmsley’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-400
Closed -$20K 649
2021
Q3
$20K Hold
400
﹤0.01% 576
2021
Q2
$23K Hold
400
﹤0.01% 586
2021
Q1
$26K Sell
400
-6
-1% -$368 ﹤0.01% 544
2020
Q4
$22K Sell
406
-309,620
-100% -$15.8M ﹤0.01% 537
2020
Q3
$13.7M Sell
310,026
-19,692
-6% -$866K 0.26% 104
2020
Q2
$13.9M Buy
329,718
+12,006
+4% +$462K 0.28% 98
2020
Q1
$12.6M Buy
317,712
+52,655
+20% +$2.23M 0.3% 94
2019
Q4
$11.8M Buy
+265,057
New +$10.2M 0.18% 113
2019
Q2
Sell
-81
Closed -$2K 739
2019
Q1
$2K Sell
81
-12,283
-99% -$375K ﹤0.01% 643
2018
Q4
$342K Buy
+12,364
New +$340K 0.01% 342

Other funds holding ACA

Thompson Siegel & Walmsley's ACA Position: Q4 2021 in Review

Thompson Siegel & Walmsley sold out of Arcosa (ACA) in Q4 2021, closing a stake of 400 shares — an estimated $20K sold.

Thompson Siegel & Walmsley first reported a position in ACA in Q4 2018 and held it in 10 quarters. The position peaked at $13.9M in Q2 2020. 248 funds tracked by Wall St. Rank hold ACA as of Q4 2021.

  • Thompson Siegel & Walmsley reported no remaining Arcosa position as of Q4 2021 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 400 Arcosa shares in Q4 2021, an estimated $20K.
  • Thompson Siegel & Walmsley first reported a position in Arcosa in Q4 2018 and held it in 10 quarters.
  • Thompson Siegel & Walmsley's Arcosa position peaked at $13.9M in Q2 2020.
  • 248 funds tracked by Wall St. Rank held Arcosa as of Q4 2021.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2021, filed 9 Feb 2022.